{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:13:11Z","timestamp":1779250391971,"version":"3.51.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Stroke is a serious complication of transcatheter aortic valve implantation (TAVI). Cerebral embolic protection devices (CEPDs) were developed to reduce periprocedural embolization; however, their clinical efficacy remains uncertain. We conducted a systematic review and meta-analysis of 8 randomized controlled trials including 11,775 patients undergoing TAVI with or without CEPDs. Primary outcomes included stroke (any, disabling, non-disabling), new ischemic lesions, and cognitive decline assessed by the Montreal Cognitive Assessment and National Institutes of Health Stroke Scale. Secondary outcomes included mortality, bleeding, vascular complications, and acute kidney injury. Data were pooled using a random-effects model, reporting risk ratios (RRs) or mean differences with corresponding 95% confidence intervals (CIs). Subgroup, meta-regression, and trial sequential analyses were performed. CEPDs did not significantly reduce any stroke (RR: 0.92, 95% CI [0.74\u20131.15],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.48), disabling stroke (RR: 0.80, 95% CI [0.57\u20131.12],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.19), or non-disabling stroke (RR: 1.08, 95% CI [0.79\u20131.46],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.64). No significant differences were observed in ischemic lesion count, National Institutes of Health Stroke Scale worsening, or Montreal Cognitive Assessment decline. The Sentinel device showed a marginal reduction in ischemic lesion count without clinical benefit. Sentinel use was associated with increased major vascular complications (RR: 1.42, 95% CI [1.01\u20132.01],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.046), and sensitivity analysis demonstrated higher acute kidney injury with CEPDs (RR: 1.38, 95% CI [1.01\u20131.88],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04). Trial sequential analyses suggested futility for most outcomes. While CEPDs capture embolic debris, they do not significantly reduce stroke or cognitive decline after TAVI, limiting support for routine use. Future efforts should focus on improved device design and identifying high-risk subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000001289","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:00:34Z","timestamp":1779249634000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation: A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis"],"prefix":"10.1097","author":[{"given":"Farhan","family":"Naeem","sequence":"first","affiliation":[{"name":"Department of Cardiology, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Qamar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Burhan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rawalpindi Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"Shehada","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed","family":"Balbaa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Farid","family":"Gadelmawla","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Menoufia University, Menoufia, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehroze","family":"Tabassum","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wright Center for Graduate Medical Education, Scranton, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Husnain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Luminis Health Anne Arundel Medical Center, Parole, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nauman","family":"Naeem","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rochester General Hospital, Rochester, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Hanif","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Muthukumar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West Virginia University, Morgantown, WV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Eltawansy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, SUNY Upstate Medical University, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Daggubati","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West Virginia University, Morgantown, WV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West Virginia University, Morgantown, WV"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jocs.14226","article-title":"TAVI and the future of aortic valve replacement.","volume":"34","author":"Howard","year":"2019","journal-title":"J Card Surg"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3390\/jcm13102997","article-title":"Transcatheter aortic valve implantation for severe chronic aortic regurgitation.","volume":"13","author":"Ahmad","year":"2024","journal-title":"J Clin Med"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fcvm.2018.00104","article-title":"Cerebrovascular events after transcatheter aortic valve implantation.","volume":"5","author":"Armijo","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4244\/EIJV8I1A20","article-title":"Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.","volume":"8","author":"Eggebrecht","year":"2012","journal-title":"EuroIntervention"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2261-14-45","article-title":"The Silent and Apparent Neurological Injury in Transcatheter Aortic Valve Implantation study (SANITY): concept, design and rationale.","volume":"14","author":"Fanning","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4244\/EIJ-D-23-00166","article-title":"Cerebral embolic protection during transcatheter heart interventions.","volume":"19","author":"Diaz","year":"2023","journal-title":"EuroIntervention"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"AB53","DOI":"10.4244\/EIJ-D-18-00454","article-title":"TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy.","volume":"14","author":"Lansky","year":"2018","journal-title":"EuroIntervention"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/jcm14124098","article-title":"Embolic protection devices in transcatheter aortic valve implantation: a narrative review of current evidence.","volume":"14","author":"Latsios","year":"2025","journal-title":"J Clin Med"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.3390\/jcm13237256","article-title":"2024 update on cerebral embolic protection after transcatheter aortic valve replacement.","volume":"13","author":"Gasior","year":"2024","journal-title":"J Clin Med"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/STROKEAHA.124.047149","article-title":"Cerebrovascular events in patients undergoing transcatheter aortic valve replacement: a review.","volume":"55","author":"Patel","year":"2024","journal-title":"Stroke"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"101127","DOI":"10.1016\/j.cpcardiol.2022.101127","article-title":"Cerebral embolic protection during transcatheter aortic valve implantation: updated systematic review and meta-analysis.","volume":"48","author":"Zahid","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jcin.2017.06.037","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures.","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"e013697","DOI":"10.1161\/CIRCINTERVENTIONS.123.013697","article-title":"Impact of cerebral embolic protection devices on disabling stroke after TAVR: updated results from the STS\/ACC TVT Registry.","volume":"17","author":"Butala","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa2415120","article-title":"Routine cerebral embolic protection during transcatheter aortic-valve implantation.","volume":"392","author":"Kharbanda","year":"2025","journal-title":"N Engl J Med"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis.","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthcare"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1017\/cts.2023.552","article-title":"Guidance on interim analysis methods in clinical trials.","volume":"7","author":"Ciolino","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"138","DOI":"10.17085\/apm.21038","article-title":"Trial sequential analysis: novel approach for meta-analysis.","volume":"16","author":"Kang","year":"2021","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial.","volume":"12","author":"Van Mieghem","year":"2016","journal-title":"EuroIntervention"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa2204961","article-title":"Cerebral Embolic protection during transcatheter aortic-valve replacement.","volume":"387","author":"Kapadia","year":"2022","journal-title":"N Engl J Med"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement.","volume":"69","author":"Kapadia","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial.","volume":"316","author":"Haussig","year":"2016","journal-title":"JAMA"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","article-title":"A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.","volume":"36","author":"Lansky","year":"2015","journal-title":"Eur Heart J"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/eurheartj\/ehab213","article-title":"A randomized evaluation of the TriGuardTM HDH cerebral embolic protection device to reduce the impact of cerebral embolic lesions after transcatheter aortic valve implantation: the REFLECT I trial.","volume":"42","author":"Lansky","year":"2021","journal-title":"Eur Heart J"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcin.2020.11.011","article-title":"Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement.","volume":"14","author":"Nazif","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2024.4278","article-title":"Cerebral embolic protection by geographic region.","volume":"10","author":"Makkar","year":"2025","journal-title":"JAMA Cardiol"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12872-023-03338-0","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.","volume":"23","author":"Wolfrum","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.shj.2023.100178","article-title":"An updated meta-analysis on cerebral embolic protection in patients undergoing transcatheter aortic valve intervention stratified by baseline surgical risk and device type.","volume":"7","author":"Khan","year":"2023","journal-title":"Struct Heart"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/heartjnl-2025-326208","article-title":"When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.","volume":"111","author":"Heuts","year":"2025","journal-title":"Heart"},{"key":"R35-20260520","first-page":"1590","article-title":"Stroke after transcatheter aortic valve replacement.","volume":"12","author":"Capodanno","year":"2019","journal-title":"JACC"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"e038869","DOI":"10.1161\/JAHA.124.038869","article-title":"Cerebral embolic protection devices in transcatheter aortic valve implantation: meta\u2010analysis with trial sequential analysis.","volume":"14","author":"Warraich","year":"2025","journal-title":"JAHA"},{"key":"R37-20260520","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/jcm14124098","article-title":"Embolic protection devices in transcatheter aortic valve implantation: a narrative review of current evidence.","volume":"14","author":"Latsios","year":"2025","journal-title":"J Clin Med"},{"key":"R38-20260520","doi-asserted-by":"crossref","first-page":"e030587","DOI":"10.1161\/JAHA.123.030587","article-title":"Role of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: an updated meta\u2010analysis.","volume":"13","author":"Kaur","year":"2024","journal-title":"JAHA"},{"key":"R39-20260520","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1038\/s41598-025-99173-8","article-title":"Risk factors and prognosis of silent cerebral infarction after transcatheter aortic valve replacement.","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:00:41Z","timestamp":1779249641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001289","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}